Introduction:
Delhi-based healthtech startup HealthPresso announced the appointment of Manuj Sanduja as Co-Founder and Chief Technology Officer (CTO). With 17 years of experience in client acquisition, product management, and cutting-edge IT solutions, Sanduja will play a pivotal role in driving HealthPresso’s innovation, digital transformation, and global growth.
Founded in 2020, HealthPresso aims to revolutionize health content for healthcare professionals, making it more accessible and efficient through artificial intelligence (AI) and automation. The startup’s flagship product, HumetaTM, is an advanced AI model that automates the creation of timely, accurate, and personalized health content, eliminating tedious manual processes for practitioners.
“Manuj Sanduja’s appointment as Co-Founder and CTO marks a significant milestone for HealthPresso,” said Dr. Swadeep Srivastava, Founder and Chief Belief Officer of HealthPresso. “His visionary approach, diverse expertise, and global experience will be instrumental as we embark on the next phase of our growth and drive digital health innovation worldwide.”
Sanduja brings to HealthPresso an impressive track record of success across engineering, product development, brand strategy, finance, and marketing. His unique blend of technical acumen and business savvy positions him well to lead HealthPresso’s product and technology teams to develop cutting-edge healthcare solutions powered by AI and automation.
“I am thrilled to take on this expanded leadership role at HealthPresso,” said Sanduja. “I look forward to collaborating with this exceptional team to harness emerging technologies that will transform how healthcare professionals access and utilize health content. Together, we will redefine the industry and make a meaningful impact on health outcomes globally.”
Sanduja’s appointment comes on the heels of HealthPresso’s $5 million Series A funding round in January, which was led by Sequoia Capital India with participation from Lightseed Ventures and prominent angel investors. The capital infusion is being used to further develop the HumetaTM platform, expand the startup’s market reach, and build out its team of healthcare and technology experts.
The COVID-19 pandemic has accelerated the adoption of digital health solutions and the demand for accessible, high-quality health information. According to a recent report by IAMAI-Praxis, the Indian healthtech market is projected to grow at a CAGR of 39% to reach $5 billion by 2023. Startups like HealthPresso that leverage AI to empower healthcare professionals with knowledge are well-positioned to capture a significant share of this burgeoning market.
“HealthPresso exemplifies the tremendous potential of India’s healthtech ecosystem to solve critical challenges and create value for patients, providers, and the healthcare system overall,” noted Rajan Anandan, Managing Director at Sequoia Capital India. “With its robust AI platform and Manuj’s deep expertise, HealthPresso is poised to become a category leader and help India establish itself as a global hub for healthcare innovation.”
Conclusion:
As HealthPresso embarks on its next chapter of growth, Sanduja’s leadership will be pivotal in developing strategic partnerships, expanding the startup’s offerings across therapeutic areas, and establishing a strong presence in key healthcare markets in Southeast Asia, the Middle East, and beyond. By equipping healthcare professionals with the knowledge they need to make better decisions and improve patient care, HealthPresso is ushering in a new era of data-driven, personalized medicine.
HealthPresso’s appointment of Manuj Sanduja as Co-Founder and CTO reinforces the immense opportunity, talent, and momentum in India’s dynamic healthtech startup ecosystem. With strong backing from marquee investors, a cutting-edge AI platform, and seasoned leadership, HealthPresso is well-equipped to accelerate India’s emergence as a leading digital health innovation hub and transform health outcomes on a global scale.
